Related Experiment Video
Updated: Feb 12, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Abstract:
A new study offers a potential treatment strategy for basal-like breast tumors. Researchers found that disrupting platelet-derived growth factor signaling-either genetically or with an antibody that blocks one form of the growth factor-can cause tumors to change to the luminal subtype, which is susceptible to antiestrogen therapies.
Insights
Disrupting platelet-derived growth factor signaling may transform basal-like breast tumors into a subtype responsive to antiestrogen therapies. This offers a novel treatment strategy for difficult-to-treat breast cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Basal-like breast tumors represent an aggressive subtype often lacking effective targeted therapies.
- Platelet-derived growth factor (PDGF) signaling is implicated in various cancer progressions.
- Tumor subtype plasticity is a critical factor in treatment resistance.
Discussion:
- This study investigates the potential of targeting platelet-derived growth factor (PDGF) signaling as a therapeutic strategy for basal-like breast cancer.
- Researchers explored methods to disrupt PDGF signaling, including genetic manipulation and antibody-based blockade.
- The study observed a phenotypic switch in basal-like tumors towards the luminal subtype upon PDGF pathway inhibition.
Key Insights:
- Disrupting PDGF signaling can induce a transition from basal-like to luminal breast tumor subtypes.
- The luminal subtype is known to be sensitive to established antiestrogen therapies.
- This subtype plasticity presents a promising avenue for treating previously resistant breast cancers.
Outlook:
- Further research is warranted to validate these findings in clinical settings.
- This strategy could potentially overcome resistance to current breast cancer treatments.
- Targeting PDGF signaling may offer a new therapeutic paradigm for basal-like breast cancer patients.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
08:56Terahertz Imaging and Characterization Protocol for Freshly Excised Breast Cancer Tumors
Published on: April 5, 2020
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Urine Studies II: Urine Culture and Sensitivity Test
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment